Session 1: News since St. Gallen 2013

Chairs: Alan S. Coates (Australia), Hans-Joerg Senn (Switzerland)

  • Surgical management of early breast cancer 2015 (Monica Morrow, USA)
  • Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification in early versus late recurrences (Daniel F. Hayes, USA)
  • Picking the optimal endocrine adjuvant treatment for pre-menopausal women (Marco Colleoni, Italy)
  • Comparative-effectiveness versus efficacy in the era of personalized medicine: Do we still need large prospective randomized trials? (Clifford Hudis, USA)
  • Discussion